1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow Topotecan: new trials by email Literature Review of Topotecan trials Research Report on Topotecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan Trilaciclib, Placebo, Topotecan - Extensive-stage Small-cell Lung Cancer | Phase 4 | Active not recruiting | Pharmacosmos A/S | 302 | 2023-10-13 | 2026-10-05 |
| Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Topotecan, Fludarabine, Cytarabine - Acute Myeloid Leukemia | Phase 4 | Completed | PETHEMA Foundation | 47 | 2003-05-01 | 2008-11-18 |
Leukemia, Myeloid, Acute (1) · Small Cell Lung Carcinoma (1)
PETHEMA Foundation (1) · Pharmacosmos A/S (1)
Spain (2)
Bueno Javier, Dr (1) · Sanchez Eva, Dr (1)